Interestingly, our study demonstrated that digoxin treatment activated the ERK1/2 and AKT pathways, leading to increased mRNA expression of Aggrecan and Col-2, suggesting its potential role in promoting ECM anabolism and counteracting the catabolic processes in disc degeneration. The gene discussed is AKT1; the disease is intervertebral disk degenerative disorder.